You just read:

Dexlansoprazole, a New Dual-Delayed Release Technology for the Treatment Of Reflux Disease, Accepted for National Approvals Within the European Union

News provided by

Takeda Pharmaceuticals Europe Ltd

19 Dec, 2013, 08:30 GMT